Six firms get licence to make crucial HIV injectable
Mitchell commended the speed with which Gilead is moving to make lecapavir accessible to people who need it.
PREMIUM Health
Mitchell Warren, the executive director of AVAC, a non-government organization involved in the HIV fight, said although the granting of licences to generic manufactures is good, it is not enough if some countries are left out. (Courtesy Photo)
By NewVision Reporter
Journalists @NewVision
HIV activists have appealed to pharmaceutical companies to ensure that all countries across the world access lenacapavir, the twice-yearly drug that was proven to be successful in preventing